ANOQUAN Drug Patent Profile
✉ Email this page to a colleague
When do Anoquan patents expire, and what generic alternatives are available?
Anoquan is a drug marketed by Shire and is included in one NDA.
The generic ingredient in ANOQUAN is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANOQUAN?
- What are the global sales for ANOQUAN?
- What is Average Wholesale Price for ANOQUAN?
Summary for ANOQUAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| DailyMed Link: | ANOQUAN at DailyMed |
US Patents and Regulatory Information for ANOQUAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shire | ANOQUAN | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 087628-001 | Oct 1, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
